Autres langues Olink Holding AB

Actions

OLK

US6807101000

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 06/06/2024			Varia. 5j.	Varia. 1 janv.
24,45 ^USD	+0,20 %		+1,83 %	-2,78 %

06/06	Le panel de surveillance immunitaire Olink® Target 48 ? la prochaine frontière dans le profilage des biomarqueurs immunitaires avec une confiance absolue	CI
30/05	Des chercheurs utilisent Olink® ? Explore pour identifier les protéines circulantes susceptibles d'avertir d'un cancer 7 ans avant le diagnostic	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence	06/06
Olink® Target 48 Immune Surveillance Panel ? the Next Frontier in Immune Biomarker Profiling with Absolute Confidence	06/06
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	30/05
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	30/05
Researchers Use Olink®? Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	30/05
Olink Holding's Q1 Net Loss Widens, Revenue Rises	13/05
Olink reports first quarter 2024 financial results	13/05
Olink Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger	10/05
UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink	10/05
UK's CMA kicks off probe into Thermo Fisher-Olink deal	10/05
Sampled Named One of the First Olink Certified Service Providers	06/05
Olink : Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liability - Form 6-K	19/04
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024	19/04
Metacon Appoints New Finance Chief	11/04
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease	02/04
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease	02/04
Olink Swings to Q4 Net Loss, Revenue Rises	25/03
Olink Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Olink publishes 2023 annual report	25/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Olink Holding AB

Actions

OLK

US6807101000

Autres langues

Filtres